当前位置：易推广 > 上海陶术生物科技有限公司 > 产品展示
企业档案
会员类型：会员
已获得易推广信誉 等级评定
(0 -40)基础信誉积累，可浏览访问
(41-90)良好信誉积累，可接洽商谈
(91+ )优质信誉积累，可持续信赖
易推广会员：5年
工商认证 【已认证】
最后认证时间：
注册号： 【已认证】
法人代表： 【已认证】
企业类型：生产商 【已认证】
注册资金：人民币万 【已认证】
产品数：86101
参观次数：3765175
自主品牌
已选条件
-
T41035Methoxyeugenol 4-O-rutinoside；甲氧基丁香酚-4-O-芸香糖苷Methoxyeugenol 4-O-rutinoside
Methoxyeugenol 4-O-rutinoside (compound 9) is a phenyl glucoside present in Daphniphyllum angustifolium bark.
价 格：￥电议型 号：T41035产 地：中国大陆
-
T40638Kaempferol-3-O-(2’’-O-β-D-glucopyl)-β-D-rutinoside；Kaempferol-3-O-(2’’-O-β-D-glucopyl)-β-D-rutinosid
Kaempferol-3-O-(2´´-O-β-D-glucopyl)-β-D-rutinoside is a naturally occurring glycoside present in the seeds of Camellia oleifera.
价 格：￥电议型 号：T40638产 地：中国大陆
-
T3S1944Darutoside；豯莶苷Darutin；Darutin|||豯莶苷
1. Darutoside (Darutin) can as an appropriate treatment for wounds. 2. Darutoside can improve skin elasticity, surface appearance and stretch mark removal, through soothing the skin, decreasing inflammation, restoring collagen and promoting collagen production.
价 格：￥电议型 号：T3S1944产 地：中国大陆
-
T39130Elsubrutinib；ElsubrutinibABBV-105；ABBV-105
Elsubrutinib (ABBV-105) is a highly active, potent, and selective orally-administered inhibitor of Bruton´s tyrosine kinase (BTK). It irreversibly inhibits the catalytic domain of BTK with an IC50 value of 0.18 μM. Elsubrutinib holds potential for the advancement of research on inflammatory diseases.
价 格：￥电议型 号：T39130产 地：中国大陆
-
T39056AtuzabrutinibAtuzabrutinibSAR 444727|||PRN473
Atuzabrutinib is a potent BTK (Bruton´s tyrosine kinase) inhibitor.
价 格：￥电议型 号：T39056产 地：中国大陆
-
T3787Didymin；香风草甙Isosakuranetin-7-O-rutinoside|||Neoponcirin；Isosakuranetin-7-O-rutinoside|||Neoponcirin|
Didymin (Neoponcirin) has antioxidant property. Didymin induces apoptosis by inhibiting N-Myc and upregulating RKIP in neuroblastoma, may used for neuroblastoma therapy. Didymin may be a potential therapeutic molecule for the treatment of neurodegenerative disorders associated with oxidative stress.
价 格：￥电议型 号：T3787产 地：中国大陆
-
T36287Pirtobrutinib；化合物PirtobrutinibPirtobrutinib
Pirtobrutinib (LOXO-305) is an advanced BTK inhibitor that displays high selectivity and operates through a non-covalent mechanism. This compound effectively inhibits various BTK C481 substitution mutations, leading to tumor regression in BTK-dependent lymphoma tumors in mouse xenograft models. Furthermore, Pirtobrutinib exhibits remarkable selectivity for BTK, with more than a 300-fold difference compared to 370 other kinases tested. Notably, at a concentration of 1 μM, Pirtobrutinib demonstrat
价 格：￥电议型 号：T36287产 地：中国大陆
-
T3626Acalabrutinib；阿可替尼ACP-196；ACP-196|||阿可替尼
Acalabrutinib (ACP-196), also known as ACP-196, is an orally available inhibitor of Bruton´s tyrosine kinase (BTK) with potential antineoplastic activity. Upon administration, ACP-196 inhibits the activity of BTK and prevents the activation of the B-cell antigen receptor (BCR) signaling pathway. This prevents both B-cell activation and BTK-mediated activation of downstream survival pathways. This leads to an inhibition of the growth of malignant B cells that overexpress BTK. BTK, a member
价 格：￥电议型 号：T3626产 地：中国大陆
-
T35844(R)-Pirtobrutinib；(R)-Pirtobrutinib(R)-Pirtobrutinib
(R)-Pirtobrutinib ((R)-LOXO-305) is a less active enantiomer of Pirtobrutinib, and Pirtobrutinib is a highly selective and non-covalent next generation BTK inhibitor. Pirtobrutinib (LOXO-305) effectively inhibits diverse BTK C481 substitution mutations[1].
价 格：￥电议型 号：T35844产 地：中国大陆
-
T33479Monoxerutin；单羟乙基芦丁Z 12007|||MonoHER|||7-Monohydroxyethylrutosid；Z 12007|||MonoHER|||7-Monohydroxyeth
Monoxerutin (MonoHER) is a vasodilator with antioxidant activity that prevents adriamycin-induced cardiotoxicity in mice and is used in the study of acute respiratory syndrome.
价 格：￥电议型 号：T33479产 地：中国大陆
-
T2603Spebrutinib；化合物SpebrutinibCC-292|||LMK-435|||AVL-292；CC-292|||LMK-435|||AVL-292
Spebrutinib (LMK-435) is an orally bioavailable, selective inhibitor of Bruton´s agammaglobulinemia tyrosine kinase (BTK), with potential antineoplastic activity.
价 格：￥电议型 号：T2603产 地：中国大陆
-
T23757Ascorbic acid, rutoside drug combination；化合物 T23757Rutinoscorbin|||Rutascorbin|||Ruta C 60|||Cerutin
Ascorbic acid, rutoside drug combination is used for treating diabetic retinopathy.
价 格：￥电议型 号：T23757产 地：中国大陆
-
T22417Rutin hydrate芸香苷水合物芦丁|||Rutoside|||Sophorin|||Quercetin-3-O-rutinoside
Rutin hydrate (Sophorin), a kind of glycoside, widely exists in many plants including citrus fruit.
价 格：￥电议型 号：T22417产 地：中国大陆
-
T21357Ibrutinib Interm 0441；化合物 T21357(S)-1-Boc-3-hydroxypiperidine|||(S)-1-Boc-3-piperidinol；(S)-1-Boc-3-
Ibrutinib Interm 0441 is a piperidine derivative with an amine protecting group and may be used in the preparation of biologically active compounds.
价 格：￥电议型 号：T21357产 地：中国大陆
-
T1835Ibrutinib；伊布替尼PCI-32765；伊布替尼|||依鲁替尼|||PCI-32765
Ibrutinib (PCI-32765) is a Bruton´s tyrosine kinase (BTK) inhibitor (IC50=0.5 nM) with irreversible and selective properties. Ibrutinib blocks BTK to inhibit the proliferation and survival of B cells, and possesses antitumor activity, which can be used for the treatment of chronic lymphocytic leukemia, among others.
价 格：￥电议型 号：T1835产 地：中国大陆
-
T18049Ibrutinib-biotin；依鲁替尼-生物素Ibrutinib-biotin
Ibrutinib-biotin is a probe that consists of Ibrutinib linked to biotin via a long chain linker, has an IC50 of 0.755-1.02 nM for BTK.
价 格：￥电议型 号：T18049产 地：中国大陆
-
T17220Vecabrutinib；维卡布鲁替尼SNS-062；SNS-062
Vecabrutinib (SNS-062) is a potent and noncovalent BTK and ITK inhibitor (Kd: 0.3 nM and 2.2 nM, respectively). Vecabrutinib displays an IC50 of 24 nM for ITK.
价 格：￥电议型 号：T17220产 地：中国大陆
-
T16730Remibrutinib；化合物RemibrutinibRemibrutinib
Remibrutinib inhibits BTK activity with an IC50 value of 0.023 μM in blood. Remibrutinib is an effective and orally active Bruton tyrosine kinase inhibitor (IC50: 1 nM). Remibrutinib has the potential for Chronic urticaria (CU) treatment.
价 格：￥电议型 号：T16730产 地：中国大陆
-
T16440Ibrutinib Racemate化合物 T16440PCI-32765 (Racemate)
Ibrutinib is a selective, irreversible Btk inhibitor (IC50: 0.5 nM). Ibrutinib Racemate is the racemate of Ibrutinib.
价 格：￥电议型 号：T16440产 地：中国大陆
-
T14357Spebrutinib besylate；化合物 T14357CC-292 (besylate)|||AVL-292 (benzenesulfonate)；CC-292 (besylate)|||AV
Spebrutinib besylate (AVL-292 benzenesulfonate; CC-292 besylate) is a Btk kinase activity inhibitor (IC50<0.5 nM, Kinact/Ki=7.69×104 M-1s-1s).
价 格：￥电议型 号：T14357产 地：中国大陆
